RodneyDavisMD

PubMed

• 67 citations
  Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.
  Jacob T. Ark, Kirk A. Keegan, Daniel A. Barocas, Todd M. Morgan, Matthew J. Resnick
  BJU International. 2014-06-01
• 32 citations
  Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.
  Yakup Kordan, Sam S. Chang, Shady Salem, Michael S. Cookson, Peter E. Clark
  The Journal of Urology. 2009-11-01
• 299 citations
  Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
  Rodney Davis, J. Stephen Jones, Daniel A. Barocas, Erik P. Castle, Erich K. Lang
  The Journal of Urology. 2012-12-01

Journal Articles

• Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.  
  Kordan Y, Chang SS, Salem S, Cookson MS, Clark PE, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA Jr, Barocas DA, J Urol. 182(5):2291-5.PMID: 19758638
• Autosomal dominant polycystic disease with renal cell carcinoma.  
  Lang EK, Davis R, J Urol. 2005 987
• Testicular presentation of sarcoidosis and organ preservation: case report and review of management strategies.  
  Massarweh NN, Bhalani VK, Shaw KK, Crawford B, Lang E, Davis R, Urology;6 7(1):200
• Positive Surgical Margins in Robotic-Assisted Radical Prostatectomy: Impact of Learning Curve on Oncologic Outcomes.  
  Atug F, Castle EP, Srivastav SK, Burgess SV, Thomas R, Davis R, Eur Urol. 49(5):866-71
• Carcinoma of the pancreas presenting with gross hematuria: diagnosis by multiphasic multidetector computerized tomography.  
  Lang EK, Gupta N, Davis R, Macchia R, J Urol. 176(2): 782
• Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy: preliminary analysis of outcomes.  
  Atug F, Castle EP, Srivastav SK, Burgess SV, Thomas R, Davis R, J Endourol 20(7): 514-8
• Robotics in urologic surgery: an evolving new technology.  
  Atug F, Castle EP, Woods M, Thomas R, Davis R, Int J Urol. 857-63
• Cost analysis of radical retropubic, perineal, and robotic prostatectomy.  
  Burgess SV, Atug F, Castle EP, Thomas R, Davis R, J Endourol. 20(10): 827-30
• Transperitoneal versus extraperitoneal robotic-assisted radical prostatectomy: : is one better than the other?  
  Atug F, Castle EP, Woods M, Thomas R, Davis R, Urology. 68(5): 1077-81
• Racial differences in pathogenetic mechanisms, prevalence, and progression of benign prostatic hyperplasia.  
  Hoke G Baker W, Barnswell C, Bennett J, Davis R, Rayford W, Urology. 924-30
• Impact of body mass index on outcomes after robot-assisted radical prostatectomy.  
  Castle EP, Atug F, Woods M, Thomas R, Davis R, World J Urol. 91-5, 2008
• Dependent Transcriptional Regulation and Activation of BMP-2-Smad Signaling by NF-B in Metastatic Prostate Cancer Cells. The Prostate.  
  Graham T.R., Odero-Marah V.A, Chung L.W., Agrawal K.C., Davis R, and Abdel-Mageed A.B, 1;69(2):168-180, PMID: 18942118
• Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 months.  
  Martin AD, Nunez RN, Pacelli A, Woods ME, Davis R, Thomas R, Andrews PE and Castle EP, BJUI PMID: 19903170
• Risks and benefits of the intercostal approach for percutaneous nephrolithotripsy.  
  Lang EK, Thomas R, Davis R, Colon I, Cheung W, Sethi E, Rudman E, Hanano A, Myers L, Kagen A, discussion 281-3.PMID: 19538762
• Lymphoproliferative disease.  
  Lang EK,Davis R, Cline K, J Urol. 173(1): 240
• Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy.  
  Kordan Y, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA Jr, Barocas DA, J Urol. PMID 19836759
• Robot-assisted vessel harvesting for penile revascularization.  
  Raynor MC, Davis R, Hellstrom Wayne JG, The Journal of Sexual Medicine .PMID 19788715
• Robotic Assisted Laparoscopic Prostatectomy Versus Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer: Comparison of Short-Term Biochemical Rec...  
  Barocas DA, Salem S, Kordan Y, Herrell SD, Chang SS, Clark PE, Davis R, Baumgartner R, Phillips S, Cookson MS, Smith JA Jr, J Urol. 183(3):990-6. PMID 20083261
• Use of Prostate Size To Predict High-Grade Prostate Cancer At Final Pathology.  
  Newton MR, Phillips, S, Chang SS, Clark PE, Cookson MS, Davis R, Fowke JH, Herrell SD, Baumgartner R, Chan R, Mishra V, Blume JD, Smith JA Jr, Barocas DA, J Urol. Sep;184(3):930-7. PMID 20643423
• Comparative Analysis Between Whole Mount Processing And Systematic Sampling Of Radical Prostatectomy Specimens: Pathological Outcomes And Risk Of Biochemical Recurrence.  
  Salem S, Chang SS, Clark PE, Davis R, Herrell SD, Kordan Y, Wills ML, Shappell SB, Baumgartner R, Phillips S, Smith Jr. JA, Cookson MS, Barocas DA, J Urol. Epub 2010 Aug 17. PMID: 20723932
• Effect of Pre-operative Nutritional Deficiency On Mortality After Radical Cystectomy For Bladder Cancer.  
  Gregg JR, Cookson MS, Phillips S, Salem S, Chang SS, Clark PE, Davis R, Stimson Jr CJ, Aghazadeh M, Smith Jr. JA, Barocas DA, Urol. Published online 12. doi: 10.1016/j.juro.2010.09.021. PMCID: 3049248
• Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: A tale of two methods.  
  Thompson IM 3rd, Salem S, Chang SS, Clark PE, Davis R, Duke Herrell S, Kordan Y, Baumgartner R, Phillips S, Smith JA Jr, Cookson MS, Barocas DA, World J Urol. PMID: 21079968
• Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort.  
  Aghazadeh MA, Barocas DA, Salem S, Clark PE, Cookson MS, Davis R, Gregg J, Stimson CJ, Smith JA Jr, Chang SS, J Urol. 85-9. PMID: 21074199
• Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy ...  
  Hayn MH, Hellenthal NJ, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, Davis R, Thomas R, Khan S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A, Ornstein..., Urology. 76(5):1111-6. PMID: 20709372
• Urinary Collecting System Invasion is a Predictor for Overall and Disease-Specific Survival in Locally Invasive Renal Cell Carcinoma.  
  Anderson CB, Clark PE, Morgan TM, Stratton KL, Herrell SD, Davis R, Cookson MS, Smith JA Jr, Chang SS, Urology.78(1):99-104. PMID:21550647
• Join now to see all

Books/Book Chapters

• Clinical Oncology 
  Chapter: Diagnosis and Treatment of Urinary Obstruction in Malignant Disease. 
  Page 599 - 608Davis R. and Richard-Davis GEditors: Abeloff M.D., Armitage J.O., Litcher A.S. Niederhuler J.E.
• Management of erectile dysfunction following radical prostatectomy. In Male Sexual Function. 
  Chapter: A Guide to clinical Management published in the Current Clinical Urology series by The Humana Press 
  Novak T.E., Bivalacqua T.J. Davis R., and Hellstrom WJG
• In Advanced Therapy of Prostate Disease. 
  Chapter: The case for observation. 
  Rozanski T.A. and Davis REditors: Martin Resnick and Ian Thompson..

Abstracts/Posters

• AB Role of metallothionein in prostate cancer progression.
  L. Human, Davis, R, Abdel-Mageed, Proc. Amer. Assoc. Cancer Res.41:432
• Re-expression of functional androgen receptor in PC-3 cells confers sensitization to radiation and anticancer drugs.
  R. Davis, D. Jia, B. Cinar, S. C. Sikka, K. Moparty, H. E. Zhau, L.W. Chung, K.C. Agrawal and A. B. Abdel-Mageed, Proc. Amer. Assoc. Cancer Res., 44:353, AACR meeting, Washington, DC
• Functional androgen receptor chemosensitizes prostate cancer cells to anticancer drugs and radiation.
  R. Davis, D. Jia, B. Cinar, S. C. Sikka, K. Moparty, H. E. Zhau, L.W. Chung, K.C. Agrawal and A. B. Abdel-Mageed, Cancer Detection and Prevention, pp S-167, ISPO, France
• In Vivo Gene Expression Profile Analysis of Prostate Cancer, A Custom cDNA Microarray: Identification of hnRPH1 as A Possible Biomarker in African American Patients.
  Dingwu Jia, Liset Human, Qiuyun Yang, Salima Hague, K. Moparty, R. Davis, Asim B. Abdel-Mageed, Int. Conference on Tumor Metastasis and Therapeutic Resistance, Philadelphia.
• In vivo gene expression profile analysis of prostate cancer by LCM, SSH and custom cDNA microarray: identification of hnRNP_H1 and SAFB2 as possible biomarkers for dis...
  D. Jia, B. R. Davis, K. Moparty, S. Hagque, and A. B. Abdel-Mageed, minisymposium at the AUA, San Antonio, TX
• Impact of body mass index on outcomes after robot assisted radical prostatectomy.
  Castle EP, Atug F, Woods M, Thomas R, Davis R, World J Urol. PMID 17940773
• Robot-Assisted Radical Cystectomy in Women: technique and initial experience.
  Benjamin H. Lowentritt, M.D., Erik P. Castle, M.D., Michael Woods, M.D., Davis R.., and Raju Thomas, M.D, J Endourol, 22(4):709-12 PMID 18419215
• Robot-Assisted Extended Pelvic Lymphadenectomy.
  Woods M, Thomas R, Davis R, J Endourol. 22(6): 1297-302, PMID 18498233
• Nomenclature of robotic procedures in urology, Working Group of Urologic Robotic Surgeons Scientific Committee.
  Castle EP, Lee D, J Endourol. 22(7):1467-70. PMID 18613788
• Robot-Assisted Vessel Harvesting for Penile Revascularization.
  Raynor MC, Davis R, Hellstrom WJ, J Sex Medicine, Volume 7, Issue 1pt1. 293-297 PMID 19788715
• Robot Assisted Laparoscopic Prostatectomy Versus Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer: Comparison of Short-Term Biochemical Recur...
  Barocas DA, Salem S, Kordan Y, Herrell SD, Chang SS, Clark PE, Davis R, Baumgartner R, Phillips S, Cookson MS, Smith JA Jr, J Urol. PMID 20083261
• An Analysis of Prognostic Factors Experience with Three Different Institutions.
  Shenassa B and Davis R. Genital Fournier’s Gangrene, Southeastern Section of the AUA Annual Meeting, Charleston, South Carolina
• Join now to see all

Lectures

• Contemporary Management Of Small Renal Masses: Partial Nephrectomy Is Associated Exclusively With Tumor Anatomic Complexity. 
• Prostate Cancer in African American Men. 
• Prostate Cancer in Louisiana. 
• Problems with the Management of Upper Urinary Tract Calculus Disease. 
• Dermatological Manifestations of Sexually Transmitted Disease. 
• Acute Urinary Retention as Indicator for Prostate Biopsy. 
• Prostate Asymmetry a Predictor of Carcinoma. 
• Worth A Second Look: Rates Of Upstaging At The Time Of Radical Cystectomy After Restaging TURBT For Persistent T1 Urothelial Carcinoma. 
• Use Of Pelvic Lymphadenectomy In Radical Cystectomy For Bladder Cancer: 10-Year Experience At A Single Institution. 
• Clonal Interaction Between Androgen-Dependant (AD) and Independent (A1) Human Prostate Cancer Cells: Role of Androgen and Transforming Growth Factor-Beta 
• Changing Utilization Of Neoadjuvant And Adjuvant Chemotherapies For Muscle-Invasive Urothelial Carcinoma After Publication Of Landmark Manuscripts. 
• Salvage Robotic-Assisted Laparoscopic Radical Prostatectomy: A Single Institution Five-Year Experience. 
• The Rising Incidence Of Fluoroquinolone Exposure And Subsequent Resistance During Prophylaxis For Transrectal Ultrasound-Guided Prostate Biopsy. 
• Salvage Robotic-Assisted Laparoscopic Radical Prostatectomy: A Single Institution Five-Year Experience. 
• Use Of Pelvic Lymphadenectomy In Radical Cystectomy For Bladder Cancer: 10-Year Experience At A Single-Institution. 
• Use Of Neoadjuvant Chemotherapy For Muscle-invasive Bladder Cancer: 10-Year Experience At A Single Institution. 
• Technology & Instruments: Robotics/Laparoscopy Moderated Poster. 939: Use Of Robotic Assisted Radical Cystectomy Versus Open Radical Cystectomy For Bladder Cancer I... 
• Perioperative Blood Transfusion And Survival In Patients Undergoing Nephrectomy For Renal Cell Carcinoma. 
• Moderator on Renal Cell Carcinoma 
• Prostate Cancer. 
• Robotic and Advanced Laparoscopy. 
• Tulane’s prostate cancer Screenings, the SELECT prostate cancer prevention trial, advances in treatments & Tulane’s prostate cancer support group. 
  New Orleans.
• Expert panelist on Current Management of Prostate Cancer 
  New Orleans .
• The Advanced Laparoscopy Course presentation. 
• Management of Superficial Bladder Cancer. 
• Join now to see all